Chapter09:DrugTherapyforCentralNervousSystemProblems
1. Whichneurotransmitterhasaninhibitoryactionwithinthecentralnervoussystem? a. Epinephrine b. Acetylcholine c. Norepinephrine d. Gamma-aminobutyricacid ANS: D Neurotransmitterscanbeexcitatoryorinhibitory.Excitatoryneurotransmittersincludeacetylcholi ne(Ach),epinephrine,andnorepinephrine.Inhibitoryneurotransmittersincludedopamine,somet ypesofserotonin,andGABA(gamma-aminobutyricacid). DIF: CognitiveLevel:Knowing REF: p.159 2. HowdoesthedrugtolcaponerelievethesymptomsofParkinsondisease? a Actsasadopamineagonist,replacingtheactivityofdopamine . b Forcesthesubstantianigratoincreasetheproductionandreleaseofnaturaldopamine . c Suppressestheactivityofanenzymethatnormallybreaksdownnaturallyoccurringdopamine . d Increasesthenumberofdopaminereceptorssitesthroughoutthecentralnervoussystem,thusinc . reasingtheeffectivenessofdopamineanddopamineagonists ANS: C Catechol-O-methyltransferase(COMT)isanenzymethatbreaksdown(metabolizes)naturallyoccurringcatech olamine-basedneurotransmitters,includingdopamine.Italsobreaksdowndopamineagonistdrugs.Catech ol-O-methyltransferase(COMT)inhibitorsaredrugsthatsuppresstheactivityoftheCOMTenzymesobo thnaturallyoccurringdopamineanddopamineagonistdrugsremainactiveinthebodylonger,helpin gtorestoretheacetylcholine– dopaminebalanceinthebrain.Entacapone(Comtan)andtolcapone(Tasmar)aretwoCOMTinhibit orsthatareusedcurrentlyforPD. DIF: CognitiveLevel:Understanding REF: p.162 3. Whyarecarbidopaandlevodopausuallygiventogether? a. Carbidopaisadopamineagonistandlevodopaisadopamineantagonist. b. Levodopaisadopamineagonistandcarbidopaisadopamineantagonist. c. Carbidopaenhancestheactionoflevodopa,andlessdrugisneeded. d. Levodopareversesorpreventsthesideeffectsofcarbidopa. ANS: C
Geschreven voor
- Instelling
- Vanderbilt University
- Vak
- Neuroscience
Documentinformatie
- Geüpload op
- 14 april 2022
- Aantal pagina's
- 8
- Geschreven in
- 2021/2022
- Type
- Tentamen (uitwerkingen)
- Bevat
- Vragen en antwoorden
Onderwerpen
-
chapter09drugtherapyforcentralnervoussystemproblems document subtitle chapter09drugtherapyforcentralnervoussystemproblems visovskyintroductiontoclinicalpharmacology
-
9thedition multiplechoic